Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 1;109(5):1535-1538.
doi: 10.1097/JS9.0000000000000088.

Artificial intelligence-enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period

Affiliations

Artificial intelligence-enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period

Chiranjib Chakraborty et al. Int J Surg. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial conflict of interest with regard to the content of this report.

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Figures

Figure 1
Figure 1
Schematic diagram showing the AI-enabled model and AI-enabled system with potential to improve diverse areas of clinical trial. (a) AI-enabled model against COVID-19 drugs. (b) The AI-enabled system with potential to improve diverse areas of clinical trial. AI, artificial intelligence; COVID-19, coronavirus disease 2019.

References

    1. Chakraborty C, Sharma AR, Sharma AR, Sharma G, Bhattacharya M, Saha RP, Lee SS. Ext ensive partnership, collaboration, and teamwork is required to stop the COVID-19 outbreak. Arch Med Res 2020;51:728–730. - PMC - PubMed
    1. Lexchin J. Are academia-pharma partnerships essential for novel drug discovery in the time of the COVID-19 pandemic? Expert Opin Drug Discov 2021;16:475–479. - PubMed
    1. Fleming N. How artificial intelligence is changing drug discovery. Nature 2018;557:S55–S57. - PubMed
    1. Ringel MS, Scannell JW, Baedeker M, Schulze U. Breaking Eroom’s Law. Nat Rev Drug Discov 2020;19:833–834. - PubMed
    1. Harrer S, Shah P, Antony B, Hu J. Artificial intelligence for clinical trial design. Trends Pharmacol Sci 2019;40:577–591. - PubMed